Efalizumab is a targeted T cell modulator, and is a humanized monoclonal antibody of CD11a, the alpha subunit of LFA-1. Efalizumab inhibits T cell activation, cutaneous T cell trafficking, and T cell adhesion to keratinocytes, can be used for plaque psoriasis research[1].
Molecular Weight:
(146.14 kDa)
Purity:
98.77
CAS Number:
[214745-43-4]
Target:
Integrin
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted